J. Scott Wolchko
2013
In 2013, J. Scott Wolchko earned a total compensation of $465.7K as Chief Financial Officer and Chief Operating Officer at Fate Therapeutics, a 38% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $64,512 |
|---|---|
| Option Awards | $145,189 |
| Salary | $256,000 |
| Total | $465,701 |
Wolchko received $256K in salary, accounting for 55% of the total pay in 2013.
Wolchko also received $64.5K in non-equity incentive plan and $145.2K in option awards.
Rankings
In 2013, J. Scott Wolchko's compensation ranked 9,590th out of 12,286 executives tracked by ExecPay. In other words, Wolchko earned more than 21.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,590 out of 12,286 | 22nd |
Division Manufacturing | 3,549 out of 4,612 | 23rd |
Major group Chemicals And Allied Products | 1,123 out of 1,466 | 23rd |
Industry group Drugs | 871 out of 1,160 | 25th |
Industry Biological Products, Except Diagnostic Substances | 149 out of 200 | 26th |
Source: SEC filing on April 2, 2015.
Wolchko's colleagues
We found two more compensation records of executives who worked with J. Scott Wolchko at Fate Therapeutics in 2013.